Last Price
1.94
Today's Change
+0.10 (5.43%)
Day's Change
1.85 - 1.98
Trading Volume
245,348
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Harry Simeonidis Mr. Harry Simeonidis
Full Time Employees: 50 50
IPO Date: 2020-12-23 2020-12-23
CIK: 0001725430 0001725430
ISIN: US36151G6008 US36151G6008
Beta: 4.72 4.72
Last Dividend: 0.00 0.00
Dcf Diff: 3.91 3.91
Dcf: -1.43 -1.43
Intelligent Bio Solutions Inc., a life sciences company, developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.